RhBMP-2 use in lumbar fusion surgery is associated with transient immediate post-operative leg pain

European Spine Journal

Volumn 21, Issue 7, 2012, Pages 1331-1337

  Rowan, Fiachra E ^a   O'Malley, Natasha ^b   Poynton, Ashley ^a,b  

^a MATER PRIVATE HOSPITAL   (Ireland)

^b CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

Author keywords

Leg pain; RhBMP 2; Spinal fusion

Indexed keywords

RECOMBINANT BONE MORPHOGENIC PROTEIN 2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEG PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSWESTRY DISABILITY INDEX; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RADICULITIS; RETROSPECTIVE STUDY; REVIEW; SPINE FUSION;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 2; CASE-CONTROL STUDIES; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERVERTEBRAL DISC DEGENERATION; LEG; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; RADICULOPATHY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL FUSION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864972186     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-011-2113-y     Document Type: Review

References (13)

1. Burkus JK, Gornet MF, Schuler TC, Kleeman TJ, Zdeblick TA (2009) Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Jt Surg Am 91(5):1181-1189
2. Shimer AL, Oner FC, Vaccaro AR (2009) Spinal reconstruction and bone morphogenetic proteins: open questions. Injury 40(Suppl 3):S32-S38
3. Crocker M, Jones TL, Rich P, Bell BA, Papadopoulos MC (2010) The clinical value of early postoperative MRI after lumbar spine surgery. Br J Neurosurg 24(1):46-50
4. Papakostidis C, Kontakis G, Bhandari M, Giannoudis PV (2008) Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a metaanalysis of the results. Spine (Phila Pa 1976) 33(19):E680-E692
5. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK (2004) Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4(5):527-538 discussion 538-539
6. 2, and high intravascular pressure. Circulation 111(18):2364-2372
7. Csiszar A, Ahmad M, Smith KE, Labinskyy N, Gao Q, Kaley G et al (2006) Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol 168(2):629-638
8. MacDonald KM, Swanstrom MM, McCarthy JJ, Nemeth BA, Guliani TA, Noonan KJ (2010) Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts. J Pediatr Orthop 30(2):199-205
9. Shahlaie K, Kim KD (2008) Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma. Spine (Phila Pa 1976) 33(21):2361-2366
10. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG (2006) Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31(24):2813-2819
11. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM (2007) Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16(8):1257-1265
12. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K (2008) Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8(6):1011-1018
13. Mannion AF, Denzler R, Dvorak J, Grob D (2010) Five year outcome of surgical decompression of the lumbar spine without fusion. Eur Spine J 19(11):1883-1891